FDA Reopens Administrative Record for Over-the-Counter Vaginal Contraceptive Drug Products

Summary

The Food and Drug Administration (FDA) is reopening the administrative record for proposed rulemaking on over-the-counter vaginal contraceptive drug products, allowing for public comment on matters discussed at a 1996 meeting of advisory committees, as part of its ongoing review of OTC drug products.